Top Markets
Coin of the day
AEON Biopharma, Inc. AEON Biopharma, Inc.

AEON Biopharma, Inc.

AEON
株式のランク #31959
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in... AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
株価
$0.262
最終同期: 2026-08-17
時価総額
$11.57M
変化(1日)
-5.00%
変化(1年)
-65.30%
US
取引 AEON Biopharma, Inc. (AEON)

カテゴリー

AEON Biopharma, Inc.(AEON)の配当利回りの履歴
AEON Biopharma, Inc.(銘柄コード: AEON)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
AEON Biopharma, Inc.(AEON)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)